Related Experiment Video
Updated: May 2, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Influence of obesity on the correlation between laryngopharyngeal reflux and obstructive sleep apnea
Marcos Marques Rodrigues1, Ralph Silveira Dibbern2, Victor José Barbosa Santos3
1Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial, Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial, Associação Médica Brasileira (ABORL-CCF/AMB), São Paulo, SP, Brasil.
Introduction:
The obstructive sleep apnea (OSA) is caused by recurrent episodes of partial or total obstruction of the upper airway lasting more than 10 seconds during sleep. Laryngopharyngeal reflux (LPR) is a variant of the disease Gastroesophageal Reflux that affects the larynx and pharynx.
Objectives:
Evaluate the influence of obesity on the relationship between RFL and OSAS in patients with OSA.
Materials And Methods:
An observational retrospective cross. We reviewed care protocol for patients with OSA that includes validated questionnaires for RFL as Sympton Reflux Index (RSI) and Reflux Finding Score (RSI), and polysomnography nasolaringofibroscopia.
Results:
105 patients were divided into obese group (39 patients) and non-obese patients (66 patients). In the evaluation of the mean RSI group of non-obese was similar between patients with mild OSA (11.96) and moderate (11.43). In the obese group the mean RSI was 6.7 in patients with mild OSA and 11.53 in patients with moderate to severe OSA (p < 0.05).
Discussion:
The subgroup of patients with OSA and RFL have several factors that promote inflammation of the upper airway. Patients with OSA should be screened and treated as the RFL increasing the quality of life.
Conclusion:
The RFL are positively correlated and OSAS in obese patients.
More Related Videos
06:46Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Drug Dosing: Obese Patients